Ovarian stimulation: how it works, which medicines are used, the risks involved, and what really matters in IUI, IVF and ICSI

The key points in 30 seconds

• Ovarian stimulation is an umbrella term. In practice, it is important to distinguish ovulation induction for absent ovulation from controlled stimulation for IVF or ICSI.
• Before treatment starts, diagnosis, ovarian reserve, age, PCOS risk, coexisting conditions and the goal of the cycle matter more than standard doses.
• Typical medicines include letrozole or clomiphene for ovulatory disorders, as well as gonadotrophins, GnRH antagonists or less commonly GnRH agonists in IVF and ICSI protocols.
• Ultrasound scans and, when needed, blood tests are not optional extras. They are the safety basis of treatment. Dose, trigger and sometimes the whole plan are adjusted around them.
• The most important serious risk is ovarian hyperstimulation syndrome. Modern protocols try to reduce that risk through individualised planning, antagonist protocols, an adjusted trigger and freeze-all where needed. ESHRE guideline 2025 on ovarian stimulation

What ovarian stimulation actually means

In everyday language, almost any hormone-guided follicle development gets called ovarian stimulation. Medically, the term is more precise. If reliable ovulation is not happening, the focus is often ovulation induction. If several eggs are meant to be collected for a procedure, the focus is controlled ovarian stimulation as part of assisted reproduction.

That distinction matters because not every stimulation cycle has the same goal, uses the same medicines or carries the same risks. Someone who only needs ovulation to happen usually needs a different approach from someone preparing for IUI, IVF or ICSI.

When stimulation may be helpful

Stimulation may be considered when ovulation is absent, very infrequent, or when several eggs are needed as part of fertility treatment. Common situations include PCOS, irregular cycles, absent ovulation after stopping hormonal contraception, IUI cycles with cautious follicle control, or IVF and ICSI cycles with planned egg collection.

But whether it truly makes sense never depends on an ultrasound finding alone. Semen quality, tubal status, age, AMH, previous response to medicines, the time available for trying to conceive, and whether a milder or more direct treatment strategy is the better fit also matter.

Who needs a proper assessment first

Before stimulation starts, it should be clarified why pregnancy has not happened so far. The WHO recommends a structured assessment instead of rushing into treatment. Depending on the starting point, that includes confirming an ovulatory disorder, assessing male-factor infertility, and checking the tubes or the uterine cavity when needed. WHO guideline on prevention, diagnosis and treatment of infertility

This is especially important with PCOS. Even if absent ovulation seems the obvious issue, male-factor infertility, tubal problems or other causes can still be involved. Focusing only on ovulation can cost valuable time.

The three most common goals of stimulation

1. To trigger ovulation in the first place

In anovulatory or very irregular cycles, the aim is usually to develop a single dominant follicle. The goal is not quantity, but a controlled and interpretable cycle with a manageable multiple pregnancy risk.

2. To support an IUI cycle with a small number of mature follicles

In IUI, stimulation is usually kept deliberately conservative. More follicles do not only increase the chance of pregnancy, they also increase the chance of multiples. That is why IUI cycles are often managed more strictly than IVF or ICSI cycles.

3. To collect several eggs for IVF or ICSI

In IVF and ICSI, several eggs are usually meant to mature because not every egg collected is mature, fertilises or develops into an embryo suitable for transfer. A higher follicle count can make sense here, but only within clear safety limits.

Which medicines are typically used

For ovulatory disorders, treatment often starts with tablets. International guidelines consider letrozole the preferred first pharmacological option in anovulatory PCOS-associated infertility, while clomiphene, metformin and gonadotrophins can have a secondary or additional role depending on the situation. PCOS guideline overview 2025

• Letrozole is often used for PCOS or anovulatory cycles and aims for monofollicular development.
• Clomiphene is still widely used, especially when letrozole is not available or not suitable.
• Metformin can play a supporting role in PCOS depending on metabolic status or clomiphene resistance, but it is not a universal default for every stimulation cycle. Review on metformin in PCOS
• Gonadotrophins by injection allow more precise control, but require closer monitoring.
• In IVF and ICSI cycles, GnRH antagonists or less commonly longer GnRH agonist protocols are also used to prevent premature ovulation.

Why the protocol is not chosen at random

The stimulation protocol depends on whether a low, average or high ovarian response is expected. Important signals include AMH, antral follicle count, age, previous stimulation cycles, PCOS, endometriosis, low body weight, higher body weight and the exact treatment method.

Antagonist protocols are now often preferred when the aim is to reduce OHSS risk. IVF and ICSI stimulation guidelines assess not only effectiveness, but also safety, especially moderate or severe OHSS. That is exactly why the best protocol is not the most aggressive one, but the one with the best balance of benefit and risk for the individual situation.

What preparation before the cycle usually looks like

Before the first injection day, the focus is not just on prescriptions. Medical history, a current ultrasound, hormone levels and sometimes additional lab work are usually used to plan the starting dose and protocol. This preparation is especially important in PCOS, previous overstimulation, very high ovarian reserve or known clotting risks.

Practical questions belong here too. Who injects when, how the trigger is timed, which clinic contact is responsible at weekends, when symptoms mean you should ring immediately, and what happens if too many or too few follicles grow. In real life, these details often matter more for safety than the theoretical name of the protocol.

How a stimulation cycle usually unfolds

1. Cycle day 1 or another hormonally defined starting point.
2. Start with tablets or daily injections according to the plan.
3. First ultrasound after several days, sometimes with hormone tests.
4. Dose adjustment and, if needed, the start of an antagonist.
5. Trigger for final egg maturation when follicle size and overall progress fit.
6. With IUI, insemination follows in the right time window. With IVF or ICSI, egg collection follows and then the lab phase begins.

Real cycles usually involve small course corrections. That is why a good cycle is rarely perfectly linear. Dose changes, extra monitoring or a later trigger are not automatically signs of a problem. They are signs of actual cycle control.

The role of ultrasound and blood tests

Ultrasound is the central tool for monitoring progress. It shows the number of follicles, how they are growing and how their sizes are distributed. In some situations, oestradiol or other hormone levels are added to interpret a strong response more accurately or to time the trigger more precisely.

Without this monitoring, treatment would largely be guesswork. With monitoring, the team can adjust for weak response, recognise overresponse early and activate a safety plan when needed. That is what makes stimulation controlled rather than hopeful.

Which symptoms are common and not automatically dangerous

Many people report pelvic pressure, a feeling of fullness, bloating, tiredness, breast tenderness, irritation at injection sites or noticeable emotional strain during stimulation. Those symptoms can be uncomfortable while still staying within the expected range.

• mild to moderate pelvic pressure
• more abdominal fullness towards the end of the cycle
• breast tenderness
• small bruises or stinging at injection sites
• more fatigue or lower tolerance for physical strain during treatment

The pattern over time matters. Stable mild pressure is different from rapidly increasing abdominal size, vomiting or shortness of breath.

The most important serious risk is OHSS

Ovarian hyperstimulation syndrome is the best-known serious complication of stimulation. It does not happen simply because the ovaries are larger. It happens because of an excessive response involving vascular changes and fluid shifts. The team is especially alert when ovarian reserve is high, PCOS is present, many follicles are growing or the response to medication is unusually strong.

Current guidelines now give prevention dedicated sections of their own. That includes the right patient selection, risk-aware dosing, antagonist protocols, adjusted trigger strategies and in some cases avoiding a fresh transfer in favour of a later one. ESHRE guideline 2025

Warning signs that mean the clinic should hear from you straight away

Severe or clearly increasing abdominal pain, rapid weight gain over a short period, obvious abdominal swelling, shortness of breath, persistent nausea with vomiting, circulation problems or very little urine output need prompt medical assessment. Even if these signs do not automatically mean OHSS, they belong with the treating clinic or urgent care, not in an online forum.

This matters especially after the trigger or after a positive pregnancy test because OHSS can also become noticeable later. Good counselling means explaining warning signs before they happen, not only after they start.

Why cycles are sometimes scaled back, delayed or cancelled

For patients, it can feel contradictory when many injections are followed by a sudden decision to slow things down. Medically, that is often a sign of good care. If too many mature follicles develop in IUI, cancelling may be the right choice because the multiple pregnancy risk becomes too high. If the response is too strong in IVF, freeze-all or a modified trigger may be the safer option.

The opposite also happens. If the response is very weak, a cycle may be stopped because the effort and the outlook no longer match. A cancelled cycle is not automatically a wasted cycle. It is often important information for the next, better-adjusted attempt.

What happens after the trigger

The trigger is not just the last injection. It is a key decision point. It defines the time window for ovulation or egg collection and also works as a safety tool. In the setting of higher OHSS risk, the trigger strategy may be chosen specifically to lower that risk, even if that means a fresh transfer is not always the best option.

After the trigger, IUI is timed to the planned insemination window. If intercourse is planned, the focus is the recommended fertile window. In IVF or ICSI, egg collection is scheduled, and then the lab determines how many eggs are mature, how many fertilise, and what the next few days will look like.

What stimulation cannot do

Stimulation can make follicles grow, but it does not turn every egg into a good-quality egg. It also does not fix severe male-factor infertility, blocked tubes on both sides or the age-related decline in egg quality. That is why a cycle with many eggs is not automatically a good cycle, and a moderate cycle is not automatically a bad one.

Overall chances still depend on many other factors, including age, sperm quality, fertilisation in the lab, embryo development, the uterine lining, transfer strategy and sometimes simply the biological variation from one cycle to the next.

What to keep in mind in everyday life during treatment

Simple rules help more than perfection. Take injections as consistently as possible, keep appointments reliably, do not add new medicines on your own, and take warning signs seriously. Towards the end of stimulation, high-impact exercise, jumping or intense strain are often not a good idea because the ovaries may be enlarged.

• Drink enough and pay attention to how your body feels without overinterpreting every small sensation.
• Only plan travel if monitoring, trigger timing and emergency contact remain realistic.
• Ask your clinic directly about sex, exercise, sauna use or pain relief instead of relying on general online rules.
• Keep a written record of which dose was taken when. That reduces mistakes and makes follow-up questions easier.

PCOS and ovarian stimulation: why planning is especially careful here

With PCOS, ovarian stimulation is especially common, but also especially sensitive. Guidelines often place letrozole ahead of clomiphene or metformin alone in anovulatory PCOS-associated infertility. If oral options are not enough, gonadotrophins can follow, ideally in a cautious and closely monitored dosing approach. WHO recommendations for PCOS-related anovulation

At the same time, PCOS is associated with a higher risk of overresponse. That is why starting dose, protocol choice, trigger and sometimes a later transfer are major safety levers in this setting. PCOS does not automatically mean worse chances, but it often does mean that cycle control needs to be especially clean.

Myths and facts about ovarian stimulation

• Myth: More eggs are always better. Fact: What matters is whether the response fits the goal of the cycle and the personal risk profile.
• Myth: If I have more side effects, the stimulation is working especially well. Fact: Symptoms say very little about the actual quality of the cycle.
• Myth: IUI should ideally produce several ovulating follicles. Fact: Too many follicles can make an IUI cycle medically problematic.
• Myth: Cycle cancellation means everything went wrong. Fact: Cancellation is often a deliberate safety decision or valuable information for the next protocol.
• Myth: Metformin is always automatically part of PCOS treatment. Fact: It can make sense, but it is not the standard in every situation and does not replace a good stimulation plan.
• Myth: If the ultrasound looks good, pregnancy is almost certain. Fact: Follicle growth is only one step. Egg quality, fertilisation and embryo development are still separate hurdles.

When it is time to discuss the next step

If a cycle did not lead to the hoped-for result, a calm follow-up discussion is worth having. Important questions include whether the dose was right, whether trigger timing made sense, whether there were too many or too few follicles, whether a different method would be more appropriate, and which safety limits should apply next time.

At the latest after repeated lack of success, the same cycle should not simply be copied again. At that point, the issue is strategy, not repetition. That is where it becomes clear whether treatment is truly individualised or just standardised.

Conclusion

Good ovarian stimulation is not a race for the highest numbers. It is controlled treatment with a clear goal, close monitoring and an honest assessment of risk. When diagnosis, protocol, monitoring and the plan for overresponse truly fit the individual situation, stimulation can be a useful and manageable part of fertility treatment.